Literature DB >> 12669457

Zebrafish: from disease modeling to drug discovery.

Amy L Rubinstein1.   

Abstract

The study of zebrafish, a leading model organism for developmental biology, is rapidly expanding to include human disease. Zebrafish models based on known disease mechanisms have been developed in several therapeutic areas, including blood diseases, diabetes, muscular dystrophy, neurodegenerative disease, angiogenesis and lipid metabolism. This review summarizes recent progress in disease model development, and outlines the potential of zebrafish to contribute to drug discovery through the identification of novel drug targets, validation of those targets and screening for new therapeutic compounds.

Entities:  

Mesh:

Year:  2003        PMID: 12669457

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  51 in total

Review 1.  Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies.

Authors:  C A Collins; J E Morgan
Journal:  Int J Exp Pathol       Date:  2003-08       Impact factor: 1.925

Review 2.  Current methods for assaying angiogenesis in vitro and in vivo.

Authors:  Carolyn A Staton; Stephen M Stribbling; Simon Tazzyman; Russell Hughes; Nicola J Brown; Claire E Lewis
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

3.  Evaluation of embryotoxicity using the zebrafish model.

Authors:  Lisa Truong; Stacey L Harper; Robert L Tanguay
Journal:  Methods Mol Biol       Date:  2011

4.  Teratological effects of a panel of sixty water-soluble toxicants on zebrafish development.

Authors:  Shaukat Ali; Jeffrey Aalders; Michael K Richardson
Journal:  Zebrafish       Date:  2014-03-20       Impact factor: 1.985

Review 5.  The zebrafish embryo model in environmental risk assessment--applications beyond acute toxicity testing.

Authors:  Stefan Scholz; Stephan Fischer; Ulrike Gündel; Eberhard Küster; Till Luckenbach; Doris Voelker
Journal:  Environ Sci Pollut Res Int       Date:  2008-06-25       Impact factor: 4.223

Review 6.  A critical analysis of current in vitro and in vivo angiogenesis assays.

Authors:  Carolyn A Staton; Malcolm W R Reed; Nicola J Brown
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

7.  Synchrotron microCT imaging of soft tissue in juvenile zebrafish reveals retinotectal projections.

Authors:  Xuying Xin; Darin Clark; Khai Chung Ang; Damian B van Rossum; Jean Copper; Xianghui Xiao; Patrick J La Riviere; Keith C Cheng
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-03-03

8.  In vivo evaluation of carbon fullerene toxicity using embryonic zebrafish.

Authors:  Crystal Y Usenko; Stacey L Harper; Robert L Tanguay
Journal:  Carbon N Y       Date:  2007-08       Impact factor: 9.594

9.  The Story of SPATA2 (Spermatogenesis-Associated Protein 2): From Sertoli Cells to Pancreatic Beta-Cells.

Authors:  Claudio Maran; Evelyne Tassone; Valentina Masola; Maurizio Onisto
Journal:  Curr Genomics       Date:  2009-08       Impact factor: 2.236

10.  High-throughput in vivo vertebrate screening.

Authors:  Carlos Pardo-Martin; Tsung-Yao Chang; Bryan Kyo Koo; Cody L Gilleland; Steven C Wasserman; Mehmet Fatih Yanik
Journal:  Nat Methods       Date:  2010-07-18       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.